Diabetes Archives

News and Trends 1 Sep 2022

Provention Bio looks to advance diabetes drug through $125M loan

U.S. biopharma company Provention Bio, Inc. has secured a term loan facility of up to $125 million with Hercules Capital, Inc. ahead of the company’s potential launch of teplizumab. The…

September 1, 2022 - 2 minutesmins - By Jim Cornall

francine kaufman senseomics diabetes management

Opinion 1 Sep 2022

The evolution of diabetes management

Diabetes management has progressed leaps and bounds in the last 100 years. Francine Kaufman, Chief Medical Officer of Senseonics, outlines how far the field has progressed and what is on…

September 1, 2022 - 6 minutesmins - By External Contributor

News and Trends 2 Aug 2022

Enrollment completed for trial looking at treatment of diabetic kidney disease

Enrollment has been completed for a study of a regenerative cell therapy investigational product for intra-renal artery administration to treat diabetic kidney disease (DKD). U.S.-based Caladrius Biosciences Inc., a clinical-stage…

August 2, 2022 - 2 minutesmins - By Liza Laws

News and Trends 2 Aug 2022

COUR NanoParticle technology halts Type 1 diabetes progression

COUR Pharmaceuticals has published details of a study with the Miller Lab at Northwestern University, looking at type 1 diabetes. COUR develops novel immune-modifying nanoparticles (COUR NanoParticles or CNPs) designed…

August 2, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 1 Aug 2022

Arecor Therapeutics adds diabetes product to portfolio after significant acquisition

Arecor Therapeutics plc has bought all of Tetris Pharma Ltd shares adding a key commercial diabetes product to its portfolio. The company says as well as expanding its portfolio, the…

August 1, 2022 - 3 minutesmins - By Liza Laws

lig biowise diagnostics antimicrobial resistance

News and Trends 7 Jul 2022

Treatments set to improve for lethal lung disease and ulcers following drug synergy data revelation

New data has been published today (July 7) evidencing findings that could lead to better treatment for people with lethal lung infections and infected diabetic foot ulcers caused by antimicrobial…

July 7, 2022 - 4 minutesmins - By Liza Laws

News and Trends 6 Jun 2022

Type 1 diabetes in the crosshairs with Imagine Pharma discovery

U.S. biotech company Imagine Pharma is showcasing its discovery of Type 1 Diabetes Activated Islet Progenitor Cells (T1D AIPCs) at the American Transplant Congress in Boston. The company said its…

June 6, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 27 May 2022

Up to 500 new jobs as Lilly invests $2.1B in new manufacturing sites

Eli Lilly and Company is boosting its manufacturing footprint by investing $2.1 billion in two new U.S. sites. The new facilities are located at Indiana’s LEAP Lebanon Innovation and Research…

May 27, 2022 - 3 minutesmins - By Jim Cornall

glucagon zealand pharma diabetes insulin immunotherapy

News and Trends 20 May 2022

Zealand Pharma’s drug for rare metabolic disease smashes phase III

After a year of slumping stock prices, Zealand Pharma is striking back, as its peptide drug improved blood sugar control in infants with the rare disease congenital hyperinsulinemia in a…

May 20, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 19 May 2022

Evotec, Sernova in partnership to develop beta cell diabetes therapy

Evotec and Sernova are set to join forces to advance a beta cell replacement therapy to treat insulin-dependent diabetes. As part of the deal, Evotec will make a €20M equity…

May 19, 2022 - 3 minutesmins - By Susannah Rodgers

In Depth 15 Nov 2021

The Future of Diabetes Treatment: Is a Cure Possible?

Diabetes has become an epidemic, sentencing over 460 million people worldwide to lifelong medication. Science is striving to find a diabetes treatment that can cure this chronic disease, but how…

November 15, 2021 - 10 minutesmins - By Clara Rodríguez Fernández

poxel diabetes Sumitomo Dainippon Pharma

News and Trends 2 Jul 2021

Poxel’s Diabetes Drug Wins Japan Nod, But Competition Remains Fierce

As French biotech Poxel marks the first market approval of its oral type 2 diabetes medication in Japan, eyes turn to the future of this drug and its rivals in…

July 2, 2021 - 5 minutesmins - By Anita Chakraverty

diabetes chronic kidney disease farxiga astraZeneca

News and Trends 8 Jun 2021

Farxiga’s Approval Fuels Chronic Kidney Disease Comeback

Until this year, there were no effective treatments for chronic kidney disease. However, the recent approval of AstraZeneca’s Farxiga alongside clinical breakthroughs and advances in precision medicine are causing the…

June 8, 2021 - 5 minutesmins - By Jonathan Smith

News and Trends 28 Jul 2020

Record Series A for Italian Biotech Funds Autoimmune Therapy

Italian biotech Enthera raised €28M in Series A funding to develop its drug candidate for type 1 diabetes and inflammatory bowel disease and take it to human trials. Enthera was…

July 28, 2020 - 3 minutesmins - By Helen Albert

In Depth 3 Mar 2020

How Immunotherapy Could Stop and Prevent Type 1 Diabetes

People with type 1 diabetes need lifelong treatments of daily insulin injections to manage their condition that still leave them at risk of long-term complications. Immunotherapy could one day become…

March 3, 2020 - 8 minutesmins - By Clara Rodríguez Fernández

sigrid therapeutics type 2 diabetes sweden

Startup Scout 7 Feb 2020

Sigrid Therapeutics Prevents Type 2 Diabetes Using Silica Powder in the Gut

In Stockholm, Sweden, Sigrid Therapeutics is developing an ingestible silica powder that can treat type 2 diabetes and obesity without being absorbed in the gut. Mission: To produce the first…

February 7, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 6 Feb 2020

Valbiotis Teams up with Nestlé to Reduce Type 2 Diabetes Risk

In a deal worth up to €67M, industry giant Nestlé Health Science will have the global rights to commercialize Valbiotis’ food supplement for lowering the rate of type 2 diabetes…

February 6, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 4 Nov 2019

Finnish Genetics Study Provides Clues for Treating Type 2 Diabetes

A genetic mutation common to Finnish populations has been found to protect against type 2 diabetes by increasing insulin in the blood, providing a potential target for new drugs. The…

November 4, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 30 Sep 2019

Update: Mixed Results for Adocia as Legal Fight with Eli Lilly Comes to a Close

Update (30/09/2019): A long legal battle between Adocia and Eli Lilly over a fast-acting insulin treatment development deal has finished with mixed results for Adocia. Eli Lilly has now paid…

September 30, 2019 - 4 minutesmins - By Editorial Team

novo nordisk type 2 diabetes semaglutide

News and Trends 23 Sep 2019

FDA Greenlights First Oral Version of Novo Nordisk’s Type 2 Diabetes Drug

The first oral drug for type 2 diabetes belonging to the class of GLP-1 agonists, developed by Novo Nordisk, has got the go-ahead from the FDA. The Danish company is…

September 23, 2019 - 2 minutesmins - By Jonathan Smith

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering